V3YL:XETRA:XETRA-Vanguard ESG North America All Cap UCITS ETF USD Income EUR (EUR)

ETF | Others |

Last Closing

USD 5.854

Change

+0.05 (+0.77)%

Market Cap

N/A

Volume

4.59K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.14 (+0.26%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.32%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.07 (+0.24%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.10 (+0.35%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.11 (+0.43%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.56 (+1.22%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+0.06 (+0.04%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.16 (+0.32%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.73 (+0.72%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+6.48 (+1.11%)

USD 80.38B

ETFs Containing V3YL:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.20% 85% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.20% 85% B 82% B
Trailing 12 Months  
Capital Gain 23.71% 83% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.71% 83% B 81% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.71% 74% C 72% C
Dividend Return 10.71% 73% C 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.47% 49% F 59% D-
Risk Adjusted Return 85.87% 89% A- 90% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.